| Literature DB >> 28832797 |
Ahmet Yüksel1, Irem Iris Kan2, Atıf Yolgösteren2, Yusuf Velioğlu3, Mustafa Çagdaş Çayır1, Orçun Gürbüz4, Gencehan Kumtepe4, Serkan Akarsu2, Murat Biçer2, Mustafa Tok2, Işık Şenkaya2.
Abstract
OBJECTIVE: : To investigate the impact of gender difference in early postoperative outcomes in elderly patients (aged 70 or older) undergoing coronary artery bypass grafting surgery.Entities:
Mesh:
Year: 2017 PMID: 28832797 PMCID: PMC5570389 DOI: 10.21470/1678-9741-2016-0071
Source DB: PubMed Journal: Braz J Cardiovasc Surg ISSN: 0102-7638
Demographic and baseline clinical characteristics of the groups.
| Group 1 (Female) | Group 2 (Male) | ||
|---|---|---|---|
| Overall (n, %) | 71 (31.8%) | 152 (68.2%) | |
| Age, years (mean±SD) | 74.3±3.4 | 74.4±3.7 | 0.82 |
| LMCA disease (n, %) | 12 (16.9%) | 28 (18.4%) | 0.85 |
| Ejection fraction <50% (n, %) | 22 (31.0%) | 36 (23.7%) | 0.27 |
| EuroSCORE I level (mean±SD) | 6.3±3.0 | 5.1±2.4 | 0.027 |
| CCS class for angina (mean±SD) | 1.68±0.93 | 1.62±0.87 | 0.42 |
| BMI, kg/m2 (mean±SD) | 27.6±4.4 | 27.4±4.1 | 0.74 |
| Hypertension (n, %) | 60 (84.5%) | 107 (70.4%) | 0.031 |
| Diabetes mellitus (n,%) | 27 (38.0%) | 40 (26.3%) | 0.06 |
| Hyperlipidemia (n,%) | 40 (56.3%) | 57 (37.5%) | 0.009 |
| Family history (n,%) | 8 (11.3%) | 11 (7.2%) | 0.17 |
| Smoking (n,%) | 8 (11.3%) | 54 (35.5%) | 0.000 |
| PAD (n,%) | 6 (8.5%) | 9 (5.9%) | 0.37 |
| COPD (n,%) | 4 (5.6%) | 11 (7.2%) | 0.44 |
| Renal dysfunction (n,%) | 5 (7.0%) | 13 (8.6%) | 0.59 |
| Chronic liver disease (n,%) | 1 (1.4%) | 1 (0.7%) | 0.15 |
| History of CVE (n,%) | 6 (8.5%) | 10 (6.6%) | 0.67 |
| History of previous PCI (n,%) | 6 (8.5%) | 16 (10.5%) | 0.81 |
BMI=body mass index; CCS=Canadian Cardiovascular Society; COPD=chronic obstructive pulmonary disease; CVE=cerebrovascular event; EuroSCORE=European System for Cardiac Operative Risk Evaluation; LMCA=left main coronary artery; PAD=peripheral arterial disease; PCI=percutaneous coronary intervention; SD=standard deviation
Intraoperative data of the groups.
| Group 1 (Female) | Group 2 (Male) | ||
|---|---|---|---|
| Off-pump CABG (n, %) | 32 (45.1%) | 57 (37.5%) | 0.28 |
| LITA use (n, %) | 66 (93.0%) | 145 (95.4%) | 0.52 |
| Number of distal bypass (mean±SD) | 2.51±0.93 | 2.67±0.89 | 0.18 |
| Complete revascularization (n, %) | 56 (78.9%) | 128 (84.2%) | 0.37 |
| Aortic cross clamp time, minutes (mean±SD) | 60.4±13.7 | 65.2±18.1 | 0.22 |
| Total CPB time, minutes (mean±SD) | 94.5±23.6 | 98.9±27.4 | 0.30 |
| Total operation time, minutes (mean±SD) | 209.5±44.3 | 217.6±50.8 | 0.51 |
CABG=coronary artery bypass grafting; CPB=cardiopulmonary bypass; LITA=left internal thoracic artery; SD=standard deviation
Postoperative outcomes of the groups.
| Group 1 (Female) | Group 2 (Male) | ||
|---|---|---|---|
| Erythrocyte suspension, units (mean±SD) | 1.70±0.55 | 1.42±0.83 | 0.21 |
| Fresh frozen plasma, units (mean±SD) | 2.06±0.77 | 1.89±0.95 | 0.12 |
| Thrombocyte suspension, units (mean±SD) | 0.21±0.03 | 0.23±0.04 | 0.67 |
| Intubation time, hours (mean±SD) | 9.3±4.4 | 8.7±5.9 | 0.40 |
| ICU stay, hours (mean±SD) | 44.0±59.2 | 36.7±33.7 | 0.24 |
| Hospital stay, days (mean±SD) | 12.1±13.2 | 10.4±8.6 | 0.25 |
| Low cardiac output syndrome (n,%) | 3 (4.2%) | 5 (3.3%) | 0.86 |
| Postoperative MI (n,%) | 2 (2.8%) | 3 (2.0%) | 1.00 |
| CVE (n,%) | 3 (4.2%) | 4 (2.6%) | 0.68 |
| Respiratory failure (n,%) | 5 (7.0%) | 6 (3.9%) | 0.33 |
| Pneumonia (n,%) | 3 (4.2%) | 4 (2.6%) | 0.68 |
| Reexploration for bleeding (n,%) | 1 (1.4%) | 2 (1.3%) | 1.00 |
| Mediastinitis (n,%) | 4 (5.6%) | 2 (1.3%) | 0.08 |
| Atrial fibrillation (n,%) | 16 (22.5%) | 41 (27.0%) | 0.62 |
| Acute renal dysfunction (n,%) | 2 (2.8%) | 4 (2.6%) | 1.00 |
| GIS complications (n,%) | 1 (1.4%) | 1 (0.7%) | 0.53 |
| In-hospital mortality (n,%) | 2 (2.8%) | 4 (2.6%) | 1.00 |
CVE=cerebrovascular event; GIS=gastrointestinal system; ICU=intensive care unit; MI=myocardial infarction; SD=standard deviation
| Abbreviations, acronyms & symbols | |
|---|---|
| CABG | = Coronary artery bypass grafting |
| CPB | = Cardiopulmonary bypass |
| CI | = Confidence interval |
| DM | = Diabetes mellitus |
| EuroSCORE I | = European System for Cardiac Operative Risk Evaluation I |
| HL | = Hyperlipidemia |
| HT | = Hypertension |
| ICU | = Intensive care unit |
| LITA | = Left internal thoracic artery |
| OPCAB | = Off-pump coronary artery bypass grafting |
| SPSS | = Statistical Package for Social Sciences |
| Authors' roles & responsibilities | |
|---|---|
| AY | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |
| IIK | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| AY | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |
| YV | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |
| MÇÇ | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |
| OG | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |
| GK | Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published |
| SA | Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published |
| MB | Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published |
| MT | Drafting the work or revising it critically for important intellectual content; |
| IŞ | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |